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Purpose: In a previous study, several quantitative trait loci (QTL) that influence age-related degeneration (ageRD) were
identified in a cross between the albino strains B6(Cg)-Tyr(c-2J)/J (B6a) and BALB/cByJ (C). The Chromosome (Chr)
6 and Chr 10 QTL were the strongest and most highly significant loci and both involved B6a protective alleles. The QTL
were responsible for 21% and 9% of the variance in phenotypes, respectively. We focused on these two QTL to identify
candidate genes.
Methods: DNA microarrays were used for the two mouse strains at four and eight months of age to identify genes that
are differentially regulated and map to either QTL. Gene Ontology (GO) analysis of the differentially expressed genes
was performed to identify possible processes and pathways associated with ageRD. To identify additional candidates,
database analyses (Positional Medline or PosMed) were used. Based on differential expression, PosMed, and the presence
of reported polymorphisms, five genes per QTL were selected for further study by sequencing analysis and qRT–PCR.
Tumor necrosis factor, alpha- induced protein 3 (Tnfaip3; on a C57BL/6J (B6) background) was phenotypically tested.
Single nucleotide polymorphisms (SNPs) flanking this gene were correlated with outer nuclear layer thickness (ONL),
and eight-month-old Tnfaip3+/− mice were tested for ageRD.
Results: Polymorphisms were found in the coding regions of eight genes. Changes in gene expression were identified by
qRT–PCR for Hexokinase 2 (Hk2) and Docking protein 1 (Dok1) at four months and for Dok1 and Tnfaip3 at eight months.
Tnfaip3 was selected for phenotypic testing due to differential expression and the presence of two nonsynonymous
mutations. However, when ONL thickness was compared in eight-month-old congenic Tnfaip3+/− and Tnfaip3+/+ mice,
no differences were found, suggesting that Tnfaip3 is not the quantitative trait gene (QTG) for the Chr 10 QTL. The GO
analysis revealed that GO terms associated with stress and cell remodeling are overrepresented in the ageRD-sensitive C
strain compared with the B6a strain with age (eight months). In the ageRD-resistant B6a strain, compared with the C
strain, GO terms associated with antioxidant response and the regulation of blood vessel size are overrepresented with
age.
Conclusions: The analyses of differentially expressed genes and the PosMed database yielded candidate genes for the
Chr 6 and Chr 10 QTL. HtrA serine peptidase 2 (Htra2), Dok1, and Tnfaip3 were deemed most promising because of their
known roles in apoptosis and our finding of nonsynonymous substitutions between B6a and C strains. While Tnfaip3 was
excluded as the QTG for the Chr 10 QTL, Dok1 and Htra2 remain good candidates for the Chr 6 QTL. Finally, the GO
term analysis further supports the general hypothesis that oxidative stress is involved in ageRD.
Age-related macular degeneration (AMD) is the most
common cause of irreversible vision loss in the Western world
[1].  It  is  a  complex  disorder  where  multiple  genes  and
environmental  factors  determine  the  phenotype.  The  first
factor  that  influences  AMD  is  age.  Age-related  macular
degeneration  occurs  predominantly  in  older  individuals,
typically  those  over  50  years  of  age.  The  most  prevalent
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environmental risk factor is smoking [2]. Smoking, which is
thought to cause oxidative stress, increases the risk of AMD,
especially  in  individuals  who  carry  a  polymorphism  in
complement  factor  H3.  Human  genetics  studies  have
identified multiple genes associated with AMD, including
complement factors H (CFH), complement factor B (CFB),
and  complement  component  2  (C2),  Chemokine  (C-X3-C
motif)  receptor  1  (CX3CR1),  Age-related  macular
susceptibility 2 (ARMS2), HtrA serine peptidase 1 (HTRA1),
Apolipoprotein E (ApoE), Vascular endothelial growth factor
A (VEGF-A), and ATP-binding cassette subfamily A (ABC1)
member 4 (ABCA4; for reviews, see [3,4]). The use of mouse
models has confirmed the involvement of some of these genes
in age-related retinal degeneration (ageRD) [3,4].
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1004We have found that gradual, spontaneous ageRD occurs
in many inbred strains of mice and often differs in rate among
strains due to their genetic background [5,6]. In particular,
BALB/cByJ (C) albino mice experience significantly more
retinal  degeneration  as  they  age  than  B6(Cg)-Tyr(c-2J)/J
(B6a) albinos [5]. This differential sensitivity is explained by
genes  present  in  quantitative  trait  loci  (QTL)  on
Chromosomes (Chrs) 6, 10, 16, 14, 18, 12, 13, and 8 (listed in
order of strength of influence on the phenotype) [5].
The goal of this study was to identify candidate genes that
might  explain  this  differential  sensitivity  to  ageRD.  We
focused on the QTL on Chrs 6 and 10, as they are highly
significant and involve B6a protective alleles (or conversely,
C degenerative alleles) that are responsible for 21% and 9%
of  the  phenotypic  variance,  respectively.  This  percent
variance is large enough to allow for phenotype testing. We
were guided by our working hypothesis that genes that are
differentially regulated between strains (in particular at eight
months  of  age)  and  are  localized  to  the  QTL  are  good
candidate genes to explain the differential sensitivity, along
with  genes  that  have  nonsynonymous  coding  region
polymorphic changes between the strains. We performed a
competitive  microarray  for  the  strains,  database  analysis
(Positional  Medline),  reported  SNP  analysis,  sequencing
analysis, and qRT–PCR to identify and study candidate genes.
Using knockout mice, one candidate gene was phenotypically
tested as a candidate for the quantitative trait gene (QTG) of
the Chr 10 QTL.
The Gene Ontology analysis of the microarray identified
processes and pathways that may modulate ageRD.
METHODS
Mice: Two albino mouse strains were used for this study:
BALB/cByJ (C) and B6(Cg)-Tyr(c-2J)/J (B6a). Both were
originally purchased from Jackson Laboratories (Bar Harbor,
ME) and were maintained in our vivarium through many
generations. The B6a mice were derived from C57BL/6J mice
and  are  homozygous  for  a  base  pair  substitution  that
inactivates the tyrosinase gene (c) making them isogenic with
B6 and rendering them albino.
Tumor  necrosis  factor,  alpha-  induced  protein  3
(Tnfaip3)+/− animals were generously provided by Dr. Averil
Ma (University of California, San Francisco, CA). To allow
for  comparison  with  B6  mice,  Tnfaip3+/−  mice  were
backcrossed onto the B6 strain to N8-N10. As Tnfaip3−/− is
lethal, N8-N10 congenic Tnfaip3+/− and Tnfaip3+/+ mice were
aged to eight months and sacrificed using CO2. Eyes were
enucleated and used for outer nuclear layer (ONL) thickness
determination. All mice were kept under a 12 h light-dark
cycle with average light intensity in the cage of 2–7 ft-c. The
temperature of the vivarium was maintained between 18 °C
and 20 °C.
The following measures were applied to ensure equal
light exposure for the animals: cages were kept on the lower
shelves of freestanding racks and the cages were rotated by
shelf  and  position  on  the  shelf  each  week.  Mice  were
maintained  on  a  low-fat  maintenance  diet  (15001  Rodent
Laboratory Chow; Newco Distributors, Rancho Cucamonga,
CA) with access to chow and water ad libitum. Mating pairs,
pregnant mice, and mothers with pups had a higher fat diet
(15015 Rodent Laboratory Chow; Newco Distributors).
All procedures were performed in accordance with the
Association  for  Research  in  Vision  and  Ophthalmology
(ARVO) Statement for the Use of Animals in Ophthalmic and
Vision  Research  and  were  approved  by  the  Loyola
Marymount University Committee on Animal Research.
Measurement of outer nuclear layer thickness: After the mice
were aged to eight months, eyes were enucleated, fixed in a
mixture of 2% formaldehyde and 2.5% glutaraldehyde in a
phosphate buffer, embedded in an Epon-Araldite mixture, and
bisected along the vertical meridian through the optic nerve
head. To enable determination of the superior and inferior
retina, the superior sclera was marked with a fine point marker
before enuclation. A single 1 µm section was taken from the
cut surface of one of the eyecup halves from each mouse and
stained with toluidine blue, as previously described [7]. In
each  of  the  superior  and  inferior  hemispheres,  the  ONL
thickness  was  measured  in  nine  sets  of  108  three
measurements  each  (a  total  of  27  measurements  in  each
hemisphere).  Each  set  was  centered  on  adjacent  250  µm
lengths of retina, with the first set centered 250 µm from the
optic  nerve  head  and  subsequent  sets  located  more
peripherally.  Within  each  250  µm  length,  the  three
measurements were made at defined points separated from
one another by 50 µm using an eyepiece micrometer. Since
the retinal length in each hemisphere was 2.25–2.75 mm, the
54 measurements in the two hemispheres sampled regions of
almost the entire retinal section [7,8].
Single  nucleotide  polymorphism  correlation  with  outer
nuclear layer thickness: As mentioned above, there is a highly
significant  QTL  on  Chr  10  that  explains  the  differential
sensitivity to ageRD in both strains of mice [5]. The Chr 10
QTL maps the position 15.4–20.8 Mb. Polymorphisms in that
region  are  highly  associated  with  ONL  thickness.  We
compared the ONL thickness of F2 animals from the original
study [5] that were polymorphic for two single nucleotide
polymorphisms  (SNPs)  that  span  Tnfaip3.  The  SNP
rs4135995 is localized 1.4 Mb downstream of Tnfaip3 and
rs1348525 is localized 0.3 Mb upstream of Tnfaip3. A one-
way ANOVA test, followed by pairwise multiple comparisons
using the Holm-Sidak method, was applied to compare the
ONL  thickness  of  mice  being  homozygous  B6a,
heterozygous, or homozygous C for the mentioned SNPs.
Microarray experiments:
RNA preparation—Posterior eyecups from both C and
B6a strains of mice (females) sacrificed at four and eight
months of age were dissected, quick frozen in a dry ice/95%
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1005ethanol bath, and stored at −80 °C. Total RNA was isolated
following homogenization of eyecups using TRIzol® solution
(Invitrogen, Carlsbad, CA). To obtain a sufficient amount of
high quality total RNA and to reduce biologic variability [9],
eyecups from three animals (six eyes) were pooled for each
sample. For each strain (C and B6a) and each age (four and
eight months), four RNA samples were obtained. A total of
48 mice were used for the microarray experiment (12 animals
for each genotype and time point).
Sample  labeling  and  microarray  hybridization—
RNA was linearly amplified using a method similar to that
described by Van Gelder, Eberwine, and coworkers [10-12].
Amplified RNA served as a template for the generation of
cDNA labeled with fluorescent dye, Cy3, or Cy5. The four-
month C samples labeled with Cy5 were hybridized with the
four-month  B6a  samples  labeled  with  Cy3  (four  biologic
replicates); the eight-month C samples labeled with Cy5 were
hybridized with the eight-month B6a samples labeled with
Cy3, for eight arrays (four biologic replicates). Another eight
hybridizations were performed on a second set of arrays with
the  same  RNA  samples  and  the  dye  orientation  reversed,
yielding a total of 16 arrays in the experiment.
The  mouse  cDNA  microarrays  used  here  were
manufactured at the Stanford Functional Genomics Facility
(Stanford, CA) and contained 42,000 cDNA clones on glass
slides  representing  ~25,000  unique  genes.  After
hybridization, the arrays were washed according to standard
procedures, scanned on an Axon 4000B scanner, and gridded
using GenePix® Pro 5.0 software. Raw data were uploaded
to the Stanford Microarray Database (SMD). Raw data and
normalized  data  were  submitted  to  the  Gene  Expression
Omnibus (GEO). The GEO accession number is GSE18151.
Data processing and normalization—The raw intensity
data for the two fluorescent channels (ch1 and ch2) were
downloaded from the SMD and the log2 (ch2/ch1) ratios for
all cDNA probes were calculated for all 16 chips. Lowess
normalization was performed so that the intensity dependence
of the log2 (ch2/ch1) ratio was corrected (with f=0.33) [13].
The parameter f is the Lowess fit applied to the log2(ch2/ch1)
versus log2 (Sqrt [ch1xch2]) plot. Subsequently, log2 ratios in
all chips were linearly re-scaled so that the standard deviation
of log2 ratios, calculated as the standard deviation among all
genes within each chip, are the same across chips and equal
to the median value of standard deviation across the 16 chips.
The dye effect (D) for each gene was estimated as follows: the
average of normalized log2 ratios for the eight C-Cy5/B6a-
Cy3 chips, plus the average of normalized log2 ratios of the
eight B6a-Cy5/C-Cy3 chips is twice the Cy5/Cy3 effect (2D).
The dye effect was removed and the B6a/C chips were flipped
to C/B6a using the following procedure: subtracting D from
the normalized log2 ratios for the eight C-Cy5/B6a-Cy3 chips
and adding D to the negative of the normalized log2 ratios for
the eight B6a-Cy5/C-Cy3 chips. Genes missing four or more
values among the eight C-Cy5/B6a-Cy3 chips or among the
eight B6a-Cy5/C-Cy3 chips were excluded. A total of 5,212
genes were removed from analysis.
The following comparisons were performed: (1) the C/
B6a  difference  in  all  16  chips  to  determine  whether  the
average of the 16 adjusted C/B6a values is significantly non-
zero, using a one-group t-test, (2) the C/B6a difference at four
months to determine whether the average of the eight chips at
four months is significantly non-zero, (3) the C/B6a difference
at  eight  months,  and  (4)  age  dependency  of  the  train
differences to determine whether C/B6a at four months is
significantly different from the C/B6a at eight months. For
these four comparisons, p-values were tabulated and the false
discovery  rate  (FDR)  from  Significance  Analysis  of
Microarrays  (SAM)  was  calculated.  False  discovery  rate
significance was set at < 0.05 for all genes.
Gene ontology analysis: Using GenMAPP and MAPPFinder
2, Gene Ontology (GO) based overrepresentation analysis was
performed on the differentially expressed genes, with FC≥1.2
or FC≤0.8 and FDR<0.05 [14]. Of the ~25,000 unique genes
present on our microarrays, 9,318 were annotated with GO
terms. Gene Ontology terms that were overrepresented in our
list of differentially expressed genes were identified according
to criteria published by Doniger et al. [15]. A ranked and
filtered list of GO terms was generated using the following
criteria: permutation p<0.01, Z score ≥2, percentage of genes
changed  >10%,  and  the  number  of  genes  changed  ≥2.
Regulated genes (FC≥1.2 or FC≤0.8 and FDR<0.05) are listed
in Appendix 1.
QTL analysis: The map position for each of the differentially
expressed  genes  was  determined  [Mouse  Genome
Informatics]  to  identify  genes  that  map  to  previously
identified QTL associated with ageRD differences between
these two strains [5].
Candidate gene search using positional medline: Positional
Medline (PosMed) is a database system created by the Riken
Genomic Science Center (Yokohama, Japan) that creates a
knowledge-based  ranking  of  candidate  genes  within  a
chromosomal  interval.  The  PosMed  program  searches  for
genes  in  a  chromosomal  interval  that  are  connected  to  a
keyword (specified by the user). According to PosMed, this
connection is established by first identifying all the documents
available  in  different  document  databases  (MEDLINE
abstracts, etc.) for the particular keyword. Then, the gene
names or symbols mentioned in all the returned documents
are  extracted  and  a  ranked  list  of  candidate  genes  in  the
chromosomal interval is established based on a Fisher’s exact
test. These additional PosMed candidate genes, which were
identified  independently  of  our  microarray  study,  were
subsequently cross-referenced on the NCBI website for eye-
specific expression and the SAGE Retina Library for retina
expression.
Sequence  analysis:  Sequence  analysis  was  performed
bidirectionally using the Taq DiDeoxy Termination Cycle
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1006Sequencing  kit  (ABI,  Foster  City,  CA).  Eye-derived  total
RNA  and  cDNA  was  obtained  as  described  above.
Overlapping PCR fragments were obtained from the cDNA
pool  using  Accuprime  Pfx  DNA  polymerase  (Invitrogen,
Carlsbad,  CA).  The  5′  and  3′  ends  of  the  mRNA  were
sequenced from PCR fragments obtained from genomic DNA.
The PCR fragments were cloned in a pJET1.2/blunt vector
(Fermentas,  Glen  Burnie,  MD)  before  sequencing  with
pJET1.2 forward and PJET1.2 reverse primers (Fermentas).
The observed SNPs were submitted to a dbSNP database.
The  Mouse  Genome  Projects  database  and  the
GeneNetwork  website  were  used  to  search  for  reported
polymorphisms in genes inside the Chr 6 and Chr 10 QTL
regions.
Quantitative polymerase chain reaction validation of gene
expression: Eyes were dissected as described above. Total
RNA was obtained using RNA-bee (Tel-Test, Friendswood,
TX). For each of the four groups (C and B6a, four and eight
months of age), the eyes of three animals (six eyes) were
pooled. The whole experiment from RNA extraction to real-
time PCR was repeated three times with different pools of
animals. The cDNA was obtained from 2 μg of total RNA
primed with oligo dT using the Superscript III First-Strand
Synthesis System kit (Invitrogen). The PCR amplifications
were  performed  as  described  previously  [16].  The  PCR
amplifications were conducted using the QuantiTect Syber
Green PCR kit (Qiagen, Valencia, CA) with 0.01 U/μl of
AmpErase UNG enzyme (Applied Biosystems, Foster City,
CA) to prevent carryover contamination. Real-time PCR was
performed  in  triplicate  in  a  GeneAmp  5700  sequence
detection system (Applied Biosystems) using the following
cycling conditions: 50 °C for 2 min, 94 °C for 15 min, 40
cycles of 94 °C for 15 s, and 58 °C for 1 min. Quantitative
values  were  obtained  using  the  cycle  number  (Ct  value),
which is inversely proportional to the amount of a specific
mRNA species in the tissue sample. Relative gene expression
levels  were  calculated  using  the  equation  y=(1+AE)ΔΔCt,
where AE is the amplification efficiency of the target gene
(set at 1.0 for all calculations), and ΔΔCt is the difference
between the mean experimental and control ΔCt values. The
ΔCt value is the difference between the Ct value for a retina-
associated  gene  and  the  β-actin  internal  reference  control
gene. The relative mRNA levels of B6a at four months were
set at one (calibrator), and the levels of the other treatments
were reported relative to it. The ANOVA test was performed
to assess if the differences in the mean values of treatments
are greater than would be expected by chance. If the ANOVA
test  was  passed,  pairwise  multiple  comparisons  were
performed using the Holm-Sidak method.
RESULTS
Microarray analysis: Gene expression in posterior eyecups in
the C and B6a strains at four and eight months of age was
compared  using  DNA  microarrays.  The  analysis  of  the
transcriptional differences between the strains (especially at
eight months of age when differences in ONL thickness are
found)  should  reveal  processes  and  pathways  involved  in
ageRD.
Table 1 shows the GO terms overrepresented in each
strain at four and eight months (regulated genes under each
term are listed in Appendix 1). Interestingly, the GO terms
overrepresented in C or B6a at eight months do not overlap,
suggesting that different signaling and metabolic processes
are taking place in the retinas of these two strains. In the C
strain, GO terms associated with tissue remodeling (‘receptor-
mediated  endocytosis’,  ‘laminin-1  complex’  and  ‘cortical
cytoskeleton  organization  and  biogenesis’),  stress  and
apoptosis (‘mitochondrial envelope’), mitosis (‘M phase of
mitotic  cell  cycle’),  signaling  (‘GTPase  activity’),  and
metabolism  (‘carboxylic  acid  metabolic  process’  and
‘porphyrin metabolic process’) were found (Table 1).
In the ageRD-resistant B6a strain, GO terms related to
vascular tone regulation (‘regulation of blood vessel size’),
chromatin  remodeling  (‘nuclear  heterochromatin’),  stress
(‘response to metal ion’), signaling (‘growth factor activity’,
‘G-coupled receptor binding’), and metabolism (‘regulation
of lipid metabolic process’, ‘ATP synthesis coupled electron
transport’) were observed (Table 1).
We interpret the results of the GO term analysis with care
because the overrepresentation of a GO term in one strain
indicates  that  mRNA  expression  levels  of  genes  in  that
pathway or process are increased with respect to the other
strain; but this does not necessarily mean that levels of protein
expression are increased or that the pathway itself is activated
because microarrays do not measure protein levels or post-
translational modifications of proteins.
The upregulation of genes of the mitochondrial envelope
in the C strain may reflect the increased apoptosis that occurs
in this strain at eight months, as two pro-apoptotic genes (Bik
and Bnip3l) are increased compared to B6a. The increase in
cell remodeling is expected to be a consequence of apoptosis.
It  is  interesting  to  note  that  two  antioxidant  genes,
Metallothionein  1  (Mt1)  and  Metallothionein  2  (Mt2;
‘response to metal ion’) are increased in the B6a strain, which
could confer protection against ageRD.
A  pathway  analysis  (MAPPs)  of  the  microarray  was
performed using GeneMAPP2. The pathways upregulated in
C and B6a are in accord with the GO terms observed (data not
shown). One of the pathways increased in C at eight months
is ‘oxidative stress’ (Figure 1).
The hypothesis that both strains differ in the capacity to
respond  to  stress  could  be  postulated  from  the  GO  term
analysis.
Finally, the differential expression of some of the genes
was confirmed by qRT–PCR (Table 2).
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1008Map positions of differentially expressed genes: In a previous
quantitative  genetics  study  about  C  and  B6a,  two  highly
significant QTL that influence ageRD were found in Chr 6
and Chr 10 [5]. The refined QTL on Chr 6 is localized to 77.5–
93.0 Mb and to 15.4–20.8 Mb on Chr 10, encompassing 247
and 38 genes in these two intervals, respectively. Of these
genes, 11 were found to be differentially expressed between
the B6a and C strains for the Chr 6 QTL (Polymerase DNA
directed  epsilon  4  (Pole4),  Chaperonin  containing  TCP1
subunit  7  (Cct7),  RICKEN  cDNA  1700019G17  gene
(1700019G17Rik), Transforming growth factor alfa (Tgfa),
Germ cell-less homolog 1 (Gmcl1), NFU1 iron-sulfur cluster
scaffold  homolog  (Nfu1),  Glutamine  fructose-6-phosphate
transaminase 1 (Gfpt1), Anthrax toxin receptor 1 (Antxr1),
Gastrokine 1 (Gkn1), Minichromosome maintenance deficit
2 mitotin (Mcm2), Coiled-coil-helix-coiled-coil-helix domain
containing  4  (Chchd4)),  and  four  were  found  to  be
differentially  expressed  for  the  Chr  10  QTL  (Coiled-coil
domain containing 28A (Ccdc28a), PERP TP53 apoptosis
effector (Perp), Peroxisomal biogenesis factor 7 (Pex7), and
Myeloblastosis oncogene (Myb); Table 3 and Table 4).
Candidate gene search based on reported polymorphisms: To
select candidate genes for further study, we looked for genes
with reported polymorphisms between C and B6a in databases
(The Mouse Genome Projects database and GeneNetwork
website).
In a previous quantitative genetics study of age-related
degeneration [6] between the strains B6 and A/J (A), several
QTL were identified, but none matched with the QTL found
in the cross between B6a (isogenic with B6) and C. Hence,
Figure 1. Oxidative stress MAPP pathway. The oxidative stress MAPP pathway was regulated at eight months (Z=2.366, permute p<0.01).
Pink boxes indicate genes increased in C strain, FDR<0.05 and orange boxes indicate genes increased in B6a, FDR<0.05. Gray boxes indicate
genes present in the data set, but not regulated. White boxes indicate genes not present in the data set. Gsr, Mgst1, Cat, Mt1, and Mt2 were
regulated only at four months. The pathway was created by Nirazid Reyes and Ismael Reyes and was adapted from Reference [39].
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1009genes that have SNPs of the haplotype B6≠C and C≠A would
be very promising to investigate. In the Chr 6 QTL, we found
SNPs in 59 genes and 29 genes with SNPs that fulfill the
haplotype. In the Chr10 QTL, we found SNPs in 24 genes and
16 genes with SNPs that fulfill the haplotype (Table 3 and
Table 5). In the Chr 6 QTL, SNPs fitting the haplotype were
found either in the exons and introns of genes; in the Crh10,
QTL SNPs fitting the haplotype were only found in the introns
of genes.
Candidate  gene  search  using  Positional  Medline:  To
supplement our search for gene candidates for mouse ageRD
QTL on Chr 6 and Chr 10, we conducted a search for candidate
genes using the PosMed database. Using the keyword “retinal
degeneration,” a list of 24 genes was obtained for the Chr 6
QTL. When using the keyword “retin*,” an additional 41
genes were obtained (data not shown). The list of 24 genes
contains two of the differentially expressed genes, Gfpt1 and
Tgfa. Using the keyword “retinal degeneration,” a list of seven
genes was obtained for the Chr10 QTL. This increased to 12
genes when the keyword “retin*” was used. Only one gene in
these  two  groups,  Perp,  corresponded  to  a  differentially
expressed gene in the microarray data.
Sequence  analysis  and  quantitative  reverse  transcriptase-
PCR validation: We consider candidate genes as those that
harbor SNPs and that fit the haplotype B6≠C and C≠A (Chr
6 QTL, 29 genes; Chr 10 QTL, 16 genes). We gave those
candidate genes a score of two if they are present in both the
PosMed list and are regulated in the microarray analysis, one
if they are present in the PosMed list or are regulated in the
microarray analysis, or zero if they do not fulfill either of the
two criteria (Table 3 and Table 5).
Differences in the expression of genes and differences in
protein activity between the two strains of mice might be due
to the presence of polymorphic SNPs. To determine whether
the presence of SNPs in the candidate genes accounts for the
difference  in  susceptibility  to  ageRD  in  these  strains,
individual  genes  were  sequenced.  For  practical  purposes,
sequencing  was  limited  to  five  genes  for  each  QTL.  We
selected genes with scores of two or one; the selection was
also based on GO terms and the literature search.
In addition, qRT–PCR was performed to determine or
verify differential expression of these genes between the C
and B6a strains.
Sequence  analysis  and  qRT–PCR  results  revealed
polymorphisms and changes in expression levels for these
candidate genes between the two strains (Table 3, Table 4,
Table 5, and Table 6). Polymorphisms were identified in the
coding regions of eight of the ten genes, and in the 5′ or 3′
UTRs of seven of the ten genes. The genes Htra2, Docking
protein 1 (Dok1), and Tnfaip3 have nonsynonymous SNPs in
exons.  None  of  the  nonsynonymous  SNPs  found  fit  the
haplotype C≠B6, C≠A. By convention, we list the B6a amino
acid first, followed by the position of the amino acid, followed
by the C amino acid. One nonsynonymous SNP (I449T) was
found  in  Htra2.  The  isoleucine  allele  found  in  B6a  is
conserved among other mouse strains. Two nonsynonymous
SNPs were identified in Dok1 (D2N and V87A), with the first
B6a amino acid (D2) being conserved among other strains,
and the second B6a amino acid (V87) not being conserved.
Two nonsynonymous SNPs were found in Tnfaip3 (E627A
and L699P). Neither of the two B6a amino acids (E627 and
L699)  is  conserved  among  other  mouse  strains.  Only  a
synonymous SNP in Antxr1 fits the haplotype. Introns of the
ten  genes  selected  contained  SNPs  that  fit  the  haplotype
C≠B6,  C≠A.  Antxr1  and  eukaryotic  elongation  factor
selenocysteine-tRNA-specific  (Eefsec)  contain  a  large
number of intronic SNPs.
Changes in gene expression by qPCR were identified in
Hk2 and Dok1 at four months and in Dok1 and Tnfaip3 at eight
months.  The  remaining  genes  showed  similar  expression
profiles between the two strains, as determined by qPCR.
Outer nuclear layer phenotype of the Tnfaip3+/− mouse on a
C57BL/6 background: Tnfaip3 was selected for further study
as a candidate gene for the Chr 10 QTL for ageRD based on
the following observations. The Tnfaip3 message of this anti-
apoptotic gene was reported to be downregulated in different
models of retinal degeneration [17]. Tnfaip3 has been shown
to be upregulated in B6 with respect to C using a different
microarray platform (B. Rohrer, data not shown). We found
no difference by microarray expression at either time point in
either strain. However, using qRT–PCR, we found a 1.3 to 1.0
increase in C with respect to B6a at eight months, but no
difference at four months (Table 5). We hypothesized that a
higher activity of functional Tnfaip3 protein in B6a confers
protection against ageRD. Considering that a difference in
ONL does not occur between the strains until between six and
TABLE 2. QRT–PCR CONFIRMATION OF EXPRESSION DIFFERENCES BETWEEN STRAINS FOR SELECTED GENES AT 8 MONTHS.
Name GO term Microarray qRT–PCR
Hmox1 Porphyrin metabolic process 1.4 1.2
Sod2 Mitochondrial envelope 1.3 1.2
Mt1 Response to metal ion 0.5 0.5
Mt2 Response to metal ion 0.5 0.6
Fold change values are expressed as C/B6a.
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/
/eight months, the upregulation of Tnfaip3 in BALB/c may
reflect overexpression of a misfunctional protein due to the
two missense SNPs observed (Table 4).
SNP analysis was performed on the genomic regions
flanking Tnfaip3 on Chr 10, covering approximately 1.4 Mb
downstream and 0.3 Mb upstream. The data were obtained
from the quantitative trait analysis previously published [5].
The ONL thicknesses of eight-month-old F2 animals (n=60)
carrying the B6a allele, the C allele, or both (heterozygous for
B6a  and  C)  were  compared  for  the  two  SNPs  that  span
Tnfaip3. The genotypes of the two SNPs flanking Tnfaip3
(rs4135995 and rs1348525) are associated with significant
differences in ONL thickness (Figure 2). Overall, an additive
effect  was  observed, with  the  B6a  allele  being  protective
(Figure 2). We bred the Tnfaip3 knockout allele onto the B6
background.  The  ONL  thickness  was  compared  in  eight-
month-old N8-N10 congenic Tnfaip3+/− and Tnfaip3+/+ mice
(Tnfaip3−/−  is  lethal).  However,  no  differences  in  ONL
thickness could be identified (p=0.91) at eight months (Figure
3). Thus, the lack of an obvious retinal phenotype in Tnfaip3+/−
 animals suggests that Tnfaip3  is not the QTG for the Chr 10
QTL.
DISCUSSION
Using a combination of gene expression, bioinformatics, and
sequencing approaches, we were able to identify candidate
genes for the Chr 6 and Chr 10 QTL responsible for the
difference in the ageRD phenotype between the C and B6a
mouse  strains.  The  GO  term  analysis  of  the  competitive
microarray revealed pathways and processes associated with
ageRD.
Identification of candidate genes: The haplotype analysis
identified 35 candidate genes for the Chr 6 QTL and 14 for
the Chr 10 QTL. Those genes were scored whether they were
present in PosMed or regulated by microarray analysis. For
the sake of practicality, we selected only five candidate genes
TABLE 4. SEQUENCING ANALYSIS OF THE SELECTED CHR6 QTL CANDIDATE GENES.
Gene Non-syn Syn 5UTR 3UTR
Hk2 0 T816C (ss161109849) G1130T (ss161109850) 0 (-)3885T
(ss161109823)
    (-)1139TA (ss161109851) T1325C (ss161109852) T1573C
(ss161109853) T1876C (ss161109854)
   
Dok1 G45A (D2N) T301C (V87A) T854C T1049C C8G (ss161109825) G1550(-)
(ss161109830)
Htra2 C1381T (T449I) (ss161109831) 0 0 0
Antxr1 0 T472C**
(ss161109833)
0 A2056G
(ss161109834)
C2057G
(ss161109835)
Eefsec 0 0 0 0
NP represents not present in the microarray. **: Out of the 10 genes sequenced in exons, only the silent single nucleotide
polymorphism (SNP) in Antxr1 fit the haplotype. Non-syn: nonsynonymous SNP. Syn represents synonymous SNP.
TABLE 5. CHR10 QTL CANDIDATE GENES WITH SNPS FITTING THE HAPLOTYPE B≠C AND A≠C.
Gene ID Introns PosMed Microarray
FC 4m
Microarray
FC 8m
qRT–PCR
FC 4m
qRT–PCR
FC 8 m
N criteria
Heca Mm.473073 3 No NP NP     0
AC153433.6 ENSAMUSG95817 3 No NP NP     0
Ccdc28a Mm.296565 19 No 1 1.3     1
Nhsl1 Mm.297971 1 No 1 1     0
Hebp2 Mm.35551 1 Yes NP NP 1.4 1.2 1
Perp Mm.28209 2 Yes 2.8 1 1.2 1 2
Tnfaip3 Mm.116683 3 Yes 1 1 1 1.3* 1
D10Bwg1379e Mm.425612 10 No 1 1     0
Olig3 Mm.156946 8 Yes NP NP     1
Il20ra Mm.234667 6 No NP NP     0
Pex7 Mm.338363 1 Yes 0.8 1     2
Map3k5 Mm.6595 8 Yes 1 1 1.2 0.9 1
Mtap7 Mm.20928 8 Yes 1 1     1
Bclaf1 Mm.294783 3 No 1 1     0
Pde7b Mm.425617 6 Yes NP NP     1
Ahi1 Mm.253280 5 Yes NP NP 1 1.1 1
NP represents not present in the microarray. *: Significant difference (p<0.05) in expression between strains obtained by
qRT–PCR. Non-syn: nonsynonymous SNP. Syn represents synonymous SNP.
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the literature search. Based on our previous study [6], the QTG
alleles need to fit the haplotype C≠B6, C≠A. Even though this
haplotype is very likely, it is also possible that polymorphisms
that  do  not  fit  the  haplotype  (C≠B6,  C=A)  produce  a
phenotype in the C background and not in the A background.
Hence, it is possible that our analysis ruled out some possible
candidate  genes.  Conversely,  our  sequencing  results
identified SNPs that do not fit the haplotype, but for the reason
mentioned above were not ruled out as being responsible for
the phenotype.
Sequence  analyses  revealed  a  wide  spectrum  of
polymorphisms between the B6a and C strains in the coding
region as well as in the 5′UTR and 3′UTR and 5′ genomic and
TABLE 6. SEQUENCING ANALYSIS OF THE SELECTED CHR10 QTL CANDIDATE GENES.
Gene Non-syn Syn 5UTR 3UTR
Hebp2 0 C306T (ss161109845)
C546G (ss161109846)
G600A (ss161109847)
A22G
(ss161109838) C44G
(ss161109839) A124G
(ss161109840) T147C
(ss161109841) A198T
(ss161109842) G208C
(ss161109843) G219A
(ss161109844)
G1687A (ss161109848)
Perp 0 0 0 T816C (ss161109849)
G1130T (ss161109850)
(-)1139TA (ss161109851)
T1325C (ss161109852)
T1573C (ss161109853)
T1876C (ss161109854)
Tnfaip3 A2114C (E627A)
(ss161109862) T2330C
(L699P) (ss161109863)
0 G148C (ss161109861) T4117G (ss161109864)
T4123C (ss161109865)
T4238C (ss161109866)
Map3k5 0 T437G (ss161109867)
C926T (ss161109868)
G3431A (ss161109869)
C3483T (ss161109870)
0 0
Ahi1 0 G2346A (ss161109872) 0 (-)3323G
(ss161109873)
NP represents not present in the microarray. **: Out of the 10 genes sequenced in exons, only the silent single nucleotide
polymorphism (SNP) in Antxr1 fit the haplotype. Non-syn: nonsynonymous SNP. Syn represents synonymous SNP.
Figure  2.  Analysis  of  SNPs  flanking
Tnfaip3.  The  outer  nuclear  layer
thickness data were obtained from our
previous study [5]. The phenotype of F2
animals (n=60), sorted by the genotype
of two single nucleotide polymorphisms
(SNPs) flanking Tnfaip3, is shown. The
outer nuclear layer thickness of the B6,
H (heterozygous), and C alleles for these
two  SNPs  are  significantly  different
(p<0.001). Mean and standard error of
the mean are shown.
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revealed differences in gene expression between the B6a and
C strains for Hk2, Dok1, and Tnfaip3 (Table 3 and Table 5).
The remaining seven genes showed similar mRNA expression
profiles  between  the  two  strains.  Protein  expression
differences may be expected due to the presence of SNPs in
the  UTRs.  Our  results  enabled  us  to  postulate  testable
hypotheses  for  three  of  the  ten  genes:  Htra2,  Dok1,  and
Tnfaip3.
High  temperature  requirement  protein  A2  (Htra2)
encodes a serine protease. No differences in gene expression
between the strains were identified. Differences in protein
activity may be caused by a nonsynonymous SNP; the B6a
amino acid is conserved among other mouse strains (but do
not fit the haplotype). The Htra2 protein has been shown to
play a role in mitochondrial homeostasis [18]. Polymorphisms
in Htra2 are associated with Parkinson disease and neuronal
degeneration  [19];  the  Htra2  knockout  mouse  has  severe
neuronal degeneration [18]. The hypothesis is that the C allele
is associated with a lower capacity of the mitochondria to cope
with  stress.  Studies  of  Htra2  knockout  mice  will  be
performed.
Dok1  acts  downstream  of  a  receptor  tyrosine  kinase.
Dok1 expression is decreased in B6a with respect to C at eight
months. Differences in protein activity could be caused by
either or both of two nonsynonymous SNPs found in the
coding region (Table 4). The first B6a amino acid (D2) is
conserved among species, but the second B6 amino acid (V87)
is not. Any of both fit the haplotype B6≠C and C≠A mentioned
above.  Dok1  protein  is  associated  with  activation,
proliferation, and migration in the nervous system [20] and
the results from the Dok1/Dok2 double knockout mice suggest
that the two proteins promote apoptosis [21]. The hypothesis
is that a lower expression or activity of Dok1 in B6a protects
against apoptosis. More studies of Dok1 knockout mice will
be performed in the future.
Tnfaip3 (tumor necrosis factor, alpha-induced protein 3)
is a zinc finger protein, the expression of which is rapidly
induced in response to tumor necrosis factor [22]. Tnfaip3
mRNA expression was found to be increased in both strains
at eight months compared to four months. At eight months,
the expression in C is 1.3 to 1.0 compared to that of B6a, as
revealed  by  qRT–PCR.  No  differences  between  the  two
strains were found by DNA microarray analysis at either time
point. Tnfaip3 has been shown to be upregulated in B6 with
respect to C using a different microarray platform (B. Rohrer,
unpublished  results).  However,  qRT–PCR  results  are
generally thought to be more reliable than DNA microarray
results.  This  anti-apoptotic  gene  has  been  shown  to  be
downregulated in different models of retinal degeneration,
such as bright light exposure and elimination of endothelin-2
[17]. Differences in protein activity may be caused by one or
both  of  the  two  nonsynonymous  coding  SNPs  (Table  5).
Neither  amino  acid  (E627  or  L699)  is  conserved  among
strains, nor do they fit the haplotype. The hypothesis is that a
higher activity of Tnfaip3 in B6a confers protection against
retinal degeneration.
Based  on  the  gene  expression  data  suggesting  the
involvement of Tnfaip3 in both genetic and environmental
models of photoreceptor degeneration, we decided to study
Tnfaip3 as a candidate QTG for the Chr 10 locus further. Two
SNPs flanking Tnfaip3 (rs4135995 and rs13480525) were
correlated  with  ONL  thickness.  The  ONL  thickness  was
positively correlated with the B6a allele, with intermediate
cell survival in the heterozygote animals, demonstrating an
additive behavior (Figure 2). However, when photoreceptor
survival was analyzed in eight-month-old Tnfaip3+/− animals,
no difference in ONL thickness could be identified in N8-N10
congenic heterozygous and wildtype mice (Figure 3). This
Figure 3. Phenotype of Tnfaip3+/− mice
on  a  B6  background  (N8–10).  Outer
nuclear layer thickness was compared
between  Tnfaip3+/−  (n=12)  and
Tnfaip3+/+ mice (n=13).
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is not the QTG for the Chr 10 QTL. However, the correlation
of Tnfaip3 SNPs and ONL differences may indicate that the
actual QTG is close to this gene.
Of the ten genes selected for study, two more genes were
ruled  out  as  candidate  genes:  Ahi1  and  Antxr1.  Ahi1  is
involved in retinal degeneration in human subjects [23]. We
found that it does not harbor non-synonymous SNPs, but
contains SNPS in introns that fit the haplotype. Using qRT–
PCR, we found no differences that might rule out this gene as
a  candidate  (Table  5).  Another  gene  that  harbors  a  great
number of SNPs in introns fitting the haplotype is Antxr1. We
did not find differences in expression using qRT–PCR (Table
5). For this gene, we detected one splicing isoform that was
expressed at the same level in both strains (not found) using
northern blotting. It was then ruled out as a candidate.
In  future  studies,  genes  that  harbor  non-synonymous
mutations that fit the haplotype, such as Cyp26b1 and Gfpt1,
need to be considered.
Pathway  analysis  in  age-related  degeneration:  Gene
Ontology analysis of the differentially expressed genes in
ageRD  was  performed  to  identify  possible  processes  and
pathways involved.
In  the  ageRD  sensitive  C  strain,  genes  of  the
mitochondrial envelope were upregulated and were probably
directly related with the apoptosis mechanisms present in this
strain at eight months. Two of those genes, Bik and Bnip3l,
are pro-apoptotic [24,25]. Gene Ontology terms associated
with cell remodeling are increased in C. Neural remodeling is
a typical consequence of photoreceptor death [26].
Even  though  oxidative  stress-related  GO  terms
themselves do not appear in the ranked list of GO terms for C
at eight months, the MAPP pathway ‘oxidative stress’ was
overrepresented  in  this  strain  at  eight  months  (Figure  1).
Genes involved in protection against oxidative stress [27-30]
are found inside this pathway: Sod2, Hmox1, Gss, and Gpx1
(Figure 1). This may indicate that the retina of the C strain at
eight months of age has an increased sensitivity to oxidative
stress compared to the B6a strain. This hypothesis is supported
by experiments using the paraquat-induced generation of free
radicals, which revealed greater sensitivity of the C-strain
retinas when compared to those from the B6 strain [31]. There
is a strong link between oxidative stress and aging in the retina
[32].
In the ageRD resistant B6a strain, the GO term ‘response
to metal ion’ is overrepresented at eight months. The genes
Mt1 and Mt2 inside this term have increased expression in B6a
relative  to  C  (Appendix  1,  associated  with  the  GO  term
“response  to  metal  ion”).  Mt1  and  Mt2  are  powerful
antioxidants  [33-37],  suggesting  that  the  B6a  retina  has
elevated  basal  levels  of  antioxidants,  making  the
photoreceptors  more  resistant  to  permanent  exposure  to
reactive oxygen species generated by the absorption of light.
Genes involved in the regulation of vascular tone are
induced  in  B6a  relative  to  C  (Appendix  1,  ‘regulation  of
vasoconstriction’). Since only the blood vessels in the retina
and not those of the choroid can autoregulate [38], changes in
gene expression should reflect an adjustment of blood flow
for the oxygen requirement of the retina. However, as two
vasoconstrictor genes (Agt, End1) and two vasodilator genes
(Calca, Atp1a2) had increased expression in B6a relative to
C, the net effect on vascular tone could not be predicted with
these results.
The  remaining  GO  terms  increased  in  both  strains,
pointing to differences in metabolism and signaling.
We interpret the results of the GO term analysis with care
because the overrepresentation of a GO term in one strain
indicates  that  mRNA  expression  levels  of  genes  in  that
pathway or process are increased with respect to the other
strain. However, this does not necessarily mean that levels of
protein expression are increased or that the pathway itself is
activated because microarrays do not measure protein levels
or post-translational modifications of proteins.
Conclusions:  In  summary,  we  have  discussed  a
functional  genomics  approach,  combining  SNP  haplotype
analysis, gene expression using microarrays, and database
mining to identify novel candidate genes for QTL associated
with ageRD. SNP analysis proved to be a useful tool to refine
the search for promising candidate genes, although in the
future studies of polymorphisms in transcription regulatory
regions need to be performed.
Further studies are now needed to provide more evidence
of the functionality, role, and relevance of these genes. These
studies include sequencing of the genes in the two strains and
the  generation  of  appropriate  knockout  mouse  strains,  or
elimination/activation of the targeted gene or pathway by
pharmacological or molecular means. We hope to test these
and other hypotheses in the future.
One of the main hypotheses that could be extracted from
the GO term analysis is that the two strains have a different
capacity to cope with oxidative stress.
Finally, the identification of modifier genes/alleles that
influence the course of ageRD in mice will provide human
gene candidates that may influence the course of monogenetic
RD phenotypes and complex genetic phenotypes like AMD.
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microarray.
To access the data, click or select the words “Appendix
1.” This will initiate the download of a compressed (pdf)
archive that contains the file.
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